These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 19147669

  • 21. Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome.
    Liern M, Colazo A, Vallejo G, Zotta E.
    Nefrologia (Engl Ed); 2021; 41(3):304-310. PubMed ID: 36166246
    [Abstract] [Full Text] [Related]

  • 22. Enalapril and prednisone in children with nephrotic-range proteinuria.
    Delucchi A, Cano F, Rodriguez E, Wolff E, Gonzalez X, Cumsille MA.
    Pediatr Nephrol; 2000 Oct; 14(12):1088-91. PubMed ID: 11045392
    [Abstract] [Full Text] [Related]

  • 23. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.
    Spinar J, Vítovec J, Soucek M, Dusek L, Pavlík T, CORD Invesigators.
    Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614
    [Abstract] [Full Text] [Related]

  • 24. Enalapril and hydroxyurea therapy for children with sickle nephropathy.
    Fitzhugh CD, Wigfall DR, Ware RE.
    Pediatr Blood Cancer; 2005 Dec; 45(7):982-5. PubMed ID: 15704213
    [Abstract] [Full Text] [Related]

  • 25. Beneficial effect of triple treatment plus immunoglobulin in experimental nephrotic syndrome.
    Akman S, Kalay S, Akkaya B, Koyun M, Akbaş H, Baysal YE, Guven AG.
    Pediatr Nephrol; 2009 Jun; 24(6):1173-80. PubMed ID: 19224250
    [Abstract] [Full Text] [Related]

  • 26. Cough induced by losartan with resolution after substitution with enalapril.
    Dashti-Khavidaki S, Faghihi T, Ahmadi F, Khalili H.
    Clin Ther; 2008 Mar; 30(3):548-51. PubMed ID: 18405793
    [Abstract] [Full Text] [Related]

  • 27. Successful treatment of a patient with nephrotic syndrome associated with chronic lymphocytic leukemia.
    Takahashi F, Ogawa Y, Hasebe N, Natori S, Tokusashi Y, Miyokawa N, Kikuchi K.
    Intern Med; 2000 Mar; 39(3):256-9. PubMed ID: 10772132
    [Abstract] [Full Text] [Related]

  • 28. Combined use of enalapril and losartan to reduce proteinuria: a question of safety.
    Ellis D.
    Am J Kidney Dis; 2002 Jan; 39(1):209-11. PubMed ID: 11774126
    [No Abstract] [Full Text] [Related]

  • 29. [Nephrotic syndrome: therapeutic possibilities].
    Meesen BP.
    Ned Tijdschr Geneeskd; 1992 May 16; 136(20):992. PubMed ID: 1317511
    [No Abstract] [Full Text] [Related]

  • 30. Changes seen in the aging kidney and the effect of blocking the renin-angiotensin system.
    Inserra F, Basso N, Ferder M, Userpater M, Stella I, Paglia N, Inserra P, Tenembaum D, Ferder L.
    Ther Adv Cardiovasc Dis; 2009 Oct 16; 3(5):341-6. PubMed ID: 19574289
    [Abstract] [Full Text] [Related]

  • 31. Long-term therapy with enalapril in patients with nephrotic-range proteinuria.
    Proesmans W, Wambeke IV, Dyck MV.
    Pediatr Nephrol; 1996 Oct 16; 10(5):587-9. PubMed ID: 8897561
    [Abstract] [Full Text] [Related]

  • 32. Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome.
    Don BR, Wada L, Kaysen GA, Schambelan M.
    Kidney Int Suppl; 1989 Nov 16; 27():S163-7. PubMed ID: 2561515
    [No Abstract] [Full Text] [Related]

  • 33. Enalapril treatment of proteinuria in normotensive children.
    Sasinka MA, Podracka L, Boor A, Jurkovic I, Mitro A, Kovacs L.
    Bratisl Lek Listy; 1999 Sep 16; 100(9):476-80. PubMed ID: 10645036
    [Abstract] [Full Text] [Related]

  • 34. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
    Katavetin P, Katavetin P.
    N Engl J Med; 2009 Oct 01; 361(14):1410-1; author reply 1411. PubMed ID: 19802919
    [No Abstract] [Full Text] [Related]

  • 35. Steroid-responsive nephrotic syndrome in a patient with nail-patella syndrome.
    Hari P, Mantan M, Dinda A, Hari S, Bagga A.
    Pediatr Nephrol; 2006 Aug 01; 21(8):1197-9. PubMed ID: 16807765
    [Abstract] [Full Text] [Related]

  • 36. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA, Davies RW.
    J Am Soc Nephrol; 1990 Nov 01; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [Abstract] [Full Text] [Related]

  • 37. Dual renin-angiotensin system blockade: in patients with single functioning kidney and proteinuria.
    Robles NR, Ruiz Jiménez B, Hernández Gallego R, Ruiz-Calero R, Sánchez Casado E, Cubero JJ.
    Eur J Intern Med; 2009 Mar 01; 20(2):186-9. PubMed ID: 19327610
    [Abstract] [Full Text] [Related]

  • 38. The effect of enalapril on skin flap viability is independent of angiotensin II AT1 receptors.
    Pazoki-Toroudi H, Ajami M, Habibey R, Hajiaboli E, Firooz A.
    Ann Plast Surg; 2009 Jun 01; 62(6):699-702. PubMed ID: 19461289
    [Abstract] [Full Text] [Related]

  • 39. Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy.
    Caletti MG, Missoni M, Vezzani C, Grignoli M, Piantanida JJ, Repetto HA, Exeni R, Rasse SM.
    Pediatr Nephrol; 2011 Aug 01; 26(8):1247-54. PubMed ID: 21533629
    [Abstract] [Full Text] [Related]

  • 40. Remission of proteinuria with treatment of Actinomyces infection: eradicating a cause of secondary membranous glomerulopathy suppresses nephrotic syndrome.
    Yoon SY, Lee SC, Park YJ, Rha SH.
    Nephrol Dial Transplant; 2009 Oct 01; 24(10):3236-9. PubMed ID: 19515799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.